China SXT Pharmaceuticals Inc Cash Flow Reinvestment Rate

Latest as of December 2022: 0.11x

China SXT Pharmaceuticals Inc cash flow reinvestment rate. China SXT Pharmaceuticals Inc (SXTC) has a Cash Flow Reinvestment Rate of 0.11x as of December 2022, reinvesting $25.28K (capex $25.28K ) from operating cash flow of $234.18K. Explore debt repayment capacity of China SXT Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.11x
(Capex + Investments) / Operating CF

Total Reinvested

$25.28K
Capex + Investments

Operating Cash Flow

$234.18K
USD

Capital Expenditures

$25.28K
USD

Cash Flow Reinvestment Rate of China SXT Pharmaceuticals Inc (2016–2020)

Cash flow reinvestment rate of China SXT Pharmaceuticals Inc from 2016 to 2020. Historical reinvestment intensity for China SXT Pharmaceuticals Inc across 5 annual periods. Explore SXTC capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

China SXT Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2016–2020)

China SXT Pharmaceuticals Inc cash flow reinvestment rate by year from 2016 to 2020. Year-by-year capital reinvestment analysis for China SXT Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash efficiency ratio of China SXT Pharmaceuticals Inc.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2020 6.32x $5.90 Million $934.25K $406.66K ▲ +23.9%
2019 5.10x $1.22 Million $239.19K $610.09K ▲ +346.5%
2018 1.14x $2.19 Million $1.92 Million $1.05 Million ▼ -91.1%
2017 12.89x $3.78 Million $293.04K $186.31K ▲ +2324.4%
2016 0.53x $96.99K $182.47K $96.99K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow